Spots Global Cancer Trial Database for Treatment Outcomes of Esophageal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Treatment Outcomes of Esophageal Cancer

Official Title: Treatment Outcomes of Esophageal Cancer

Study ID: NCT05177393

Conditions

Esophageal Cancer

Interventions

Assessment of patient-reported outcomes (PROs)

Study Description

Brief Summary: This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.

Detailed Description: SPECIFIC AIMS: Aim 1: To describe the types of treatments administered for all patients diagnosed with EC at participating AfrECC sites, including chemotherapeutic regimens, radiation therapy, chemo-radiotherapy, esophageal stenting, esophagectomy, and basic supportive care. Aim 2: To evaluate the effect of different EC treatment modalities on patient reported outcomes during and after completion of treatment. Aim 3: To measure the effect of different treatment modalities on overall survival.